Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Always good to have an opinion. Mine is that the company is showing maturity in improving management. When founders reach a certain level (Peter principle) - for which they should have been preparing for years - they should step aside and get out of their own way to let the business fully develop. This is what Jushi with Caciappo and Mauff are doing. And I like it. It will pay off, and they know it, that's why they are doing it.
$ZNOG Very interesting, thanks for posting!
$ALPP Good move, glad to see it! Great management in Alpine 4.
Hmmmm... the media blowing "this" up? As in "opportunistic fear mongering?" Sorta like what they've been doing with the politics for the past several years? And sorta like what some folks do in social media to spread FUD (fear, uncertainty and doubt) among investors and traders to curb stock buying interest - or to precipitate selling - in certain market sectors whenever it suits them?
Nope. Never heard of that.
$RXMD It IS a good morning. Buying/Holding golden RXMD... much better than gold!
$IPSI Over $0.5 million someone loaded EOD. Clearly they are not interested in seeing the price move too quickly or they would have easily finished at .11+ rather than paint it down after buying over 5 million shares in two quick strikes. There's been quiet loading going on for quite some time.
$ALPP Any dips are always a good time to add.
Are you an idiot?
$JUSHF Jushi Holdings Inc. Announced its Subsidiary, Franklin Bioscience - NE LLC, Will Open Its 19th BEYOND / HELLO™ Retail Location Nationwide and 12th Store in Pennsylvania
June 04, 2021 07:00 ET | Source: Jushi Holdings Inc.
...
BEYOND / HELLO™ Hazleton’s New Retail Design System is Focused on Enhancing the Retail Experience for Pennsylvania Patients
Storefront Expands Access for Patients in Northeast Pennsylvania
BOCA RATON, Fla., June 04, 2021 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF), a vertically integrated, multi-state cannabis operator, announced its subsidiary, Franklin Bioscience - NE LLC, will open the Company’s 12th BEYOND / HELLO™ medical marijuana dispensary in Pennsylvania, and the 19th BEYOND / HELLO™ retail location nationally. BEYOND / HELLO™ Hazleton will begin serving patients and caregivers on Monday, June 7, 2021 at 10:00 a.m., providing an unparalleled in-store experience, coupled with convenient in-store express pickup and online reservations available through beyond-hello.com.
“Pennsylvania continues to be one of the best medical marijuana programs in the country, and the opening of our 12th store location in the Commonwealth is further proof of our continued commitment to broaden access for patients,” said Jim Cacioppo, Chief Executive Officer, Chairman and Founder of Jushi. “Our new store location combines a modern retail design and in-store experience with our best-in-class digital platform.”
Jushi subsidiaries plan to open an additional six new dispensaries before year end, which is expected to continue to deliver added value to Pennsylvania patients.
BEYOND / HELLO™ Hazleton is the second Pennsylvania location built with the Company’s new retail design system that is focused on patient flow, accessibility, safety, and providing an in-store experience that goes beyond the traditional cannabis retail environment. The new storefront, centrally located at 1000 West 15th Street, will be open Monday through Saturday from 9:00 a.m. to 8:00 p.m. and on Sunday from 10:00 a.m. to 6:00 p.m.
The new dispensary will carry dry leaf, concentrates, cartridges, tinctures, topicals, capsules, pills and various ancillary products such as approved batteries and devices. As a part of BEYOND / HELLO’s commitment to exceeding patient expectations, a licensed pharmacist along with experienced well-trained staff, will also be on-site to dispense products, answer questions and provide service to patients and caregivers. In addition, BEYOND / HELLO™ Hazleton is handicap accessible, LGBTQIA+ friendly and offers a 10% discount to anyone 65 years or older, veterans and active military personnel with proper identification.
For more information, visit https://jushico.com and https://beyond-hello.com.
About Jushi Holdings Inc.
We are a vertically integrated cannabis company led by an industry-leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts, and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. For more information, please visit www.jushico.com or our social media channels, Instagram, Facebook, Twitter, and LinkedIn.
Forward-Looking Information and Statements
This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current conditions but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, involve estimates, projections, plans, goals, forecasts, and assumptions that may prove to be inaccurate. As a result, actual results could differ materially from those expressed by such forward-looking statements and such statements should not be relied upon. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans,” “expects” or “does not expect,” “is expected,” “budget,” “scheduled,” “estimates,” “forecasts,” “intends,” “anticipates” or “does not anticipate,” or “believes,” or variations of such words and phrases or may contain statements that certain actions, events or results “may,” “could,” “would,” “might” or “will be taken,” “will continue,” “will occur” or “will be achieved”.
By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has certain expectations and has made certain assumptions. Expectations, assumptions, and risk factors are more fully described in the Company’s Management, Discussion and Analysis for the three months ended September 30, 2020, and other filings with securities and regulatory authorities which are available at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.
For further information, please contact:
Investor Relations Contact:
Michael Perlman
Executive Vice President of Investor Relations and Treasury
561-281-0247
Investors@jushico.com
Media Contact:
Ellen Mellody
MATTIO Communications
570-209-2947
Ellen@Mattio.com
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/2adeffe2-39b3-44d6-bb8c-f09b385efd55
https://www.globenewswire.com/NewsRoom/AttachmentNg/e9e68000-2212-4d2c-b363-bc81d4ab1fdf
https://www.globenewswire.com/NewsRoom/AttachmentNg/77dea6d3-bbd0-4955-a5bb-2c15dd8132f7
$FOMC Great news for longs! SMART move by management!!
https://www.sec.gov/Archives/edgar/data/0000867028/000149315221013298/form8-k.htm
Item 8.01 Other Events.
Effective May 31, 2021, FOMO CORP. (“FOMO”) terminated its letter of intent (“LOI”) signed on or around February 7, 2021 to acquire 100% of the shares of an HVAC services contractor. As a result, the Company will no longer issue 650,000 Series B Preferred Shares equivalent to 650 million common shares, pay $1 million in cash, or assume a $500,000 seller note. FOMO is negotiating an earn-out formula and/or vesting schedule for a deposit issued to the Seller of 100,000 Series B Preferred shares. As part of the LOI termination, FOMO and the contractor will remain partners; however, the Company will not provide the contractor right of first refusal on business, will be freed to work with any vendor, and now requires all FOMO projects to be competitively bid. Management believes the move is in the best interests of the Company as it seeks to bid on, be awarded, and execute on multiple large projects in the sales funnels of company-owned businesses and acquisition targets in the United States and abroad.
$RXMD Yes, great news for sure! I'm patient, and would MUCH rather see Iliad out of the way prior to an RS for uplist.
RXMD Well that's the danger with company insiders talking to shareholders informally. There's always going to be a certain amount of miscommunication.
Quarterly reports simply are NOT audited. Period. (same thing for big board stocks - take a look at this quarterly from Party City, for example: https://www.sec.gov/ix?doc=/Archives/edgar/data/1592058/000156459021026026/prty-10q_20210331.htm)
HOWEVER - in my experience with CEOs and other company insiders that are NOT very technical CFO types, they routinely talk about all of their reports Qs as well as Ks and refer to ALL financial reports as "audited." The reason for this is that they go through essentially the same process as the audited Annual Reports. The back-and-forth between the company and the independent accountant - the same one that stamps the Annual Report "audited" - is very similar from the company's perspective, whether a Q (quarterly, unaudited) or a K (annual, audited).
For MOST (not ALL) intents and purposes, they ARE audited, as they are reviewed and essentially controlled by the same AUDITING independent accountant that stamps their "AUDITED" certification on the 10-K Annual Report.
Exactly what I expected and exactly what I wanted to see. This is confirmation that there's no way in H3ll we're taking on that kind of debt/liability. We don't need it. We'll take Oleg when he's ready, but we don't need the rest that would come with the Net Element business.
My best guess has always been that Armen tapped Oleg to 1) run the business as the new CEO, but also 2) to help make a Nasdaq IPO a raging success. The IPO could include a capital raise, which is a great thing when combined with Progressive Care's growth posture, and could also provide a first opportunity for insiders and possibly other large shareholders to cash in a few chips.
$ALPP Absolutely, Alpine 4 has achieved amazing growth and overall business development over the past year. Those who've been around for the past few years or more definitely appreciate the awesome job management has done - and especially throughout this whole pandemic situation.
$JUSHF Well, there we go. That was certainly an interesting buy. 175,000 shares just went off, paying up to 7.49/shr. That buy was right around $1.3M.
$ETFM Interesting - reversal off of 100sma confirmed, and up 3.75% on a solid up trend.
Buy Volume: 26,843,136
Sell Volume: 16,037,088
This is going to be one MASSIVE cup-and-handle! I suggest proper DD and looking now for a position at the bottom of the cup.
Next resistance .011 at 50sma - can easily blow through that way point toward breaking .0268 at the lip of the cup and into blue sky.
4/29 +3.75% to close at .0083
4/28 +2.56% to close at .0080
4/27 +14.71% to close at .0078
4/19 to 4/26: the new "bottom" at .0068
2/17 52-week high close at .0268
Engine rumbling, earth shaking, ready to rally.
https://www.stockscores.com/chart.asp?TickerSymbol=ETFM&TimeRange=180&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=BB&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=100&Indicator1=RSI&Indicator2=AccDist&Indicator3=MACD&Indicator4=FStoch&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen
$ETFM Interesting SPOOF that appears every now and then, just like recently at .0084 and now at .0085. Suggestion: whomever places that order, leave it sit and risk losing those shares, or... guess what kind of manipulation the SEC is cracking down on lately, ESPECIALLY re OTC trading?? lol, GLMF.
$ETFM It's ready. At a great place in the news cycle, as well. Looks like a real good time to add.
$JUSHF Just out - expect to see some interesting trades on the tape next week:
$SHWZ This one's a sleeper, will get noticed!
$SHWZ For Q1 ended March31,2021, Company grew 503%
Schwazze to Host First Quarter 2021 Conference Call and Webcast - May 13, 2021
First Quarter 2021 Preliminary Revenue Increases 503% to $19.3 Million Compared to $3.2 Million During the Same Period Last Year
First Quarter 2021 Proforma Revenue was $26.8 Million
Announces Participation in Two Virtual Investor Conferences in May
DENVER--(BUSINESS WIRE)-- Schwazze, (OTCQX: SHWZ) ("Schwazze" or “the Company"), announces that it will host a first quarter 2021 conference call and webcast on May 13, 2021 at 4:30 p.m. ET.
Investors and stakeholders may participate in the conference call by dialing (201) 389-0879 or listen to the webcast from the Company's website at https://ir.schwazze.com. The webcast will be available on the Company’s website.
Following their prepared remarks, Chief Executive Officer, Justin Dye and Chief Financial Officer, Nancy Huber will answer investor questions. Investors may submit questions in advance or during the conference call itself through the weblink: http://public.viavid.com/index.php?id=144562. This weblink has been posted to the Company’s website and will be archived on the website. All Company SEC filings can also be accessed on the Company website at https://ir.schwazze.com/sec-filings
Preliminary First Quarter 2021 Revenue
For the first quarter ended March 31, 2021, the Company grew 503%, with revenue of approximately $19.3 million, compared to $3.2 million during the same period in 2020. The increase can largely be attributed to the revenue associated with the acquisition of Mesa Organics completed in April 2020 and Star Buds completed between December 2020 and March 2021. Including the revenue generated from the Star Buds dispensaries assets acquired after January 1, 2021 as if they had been acquired on January 1, 2021; proforma revenue would have been $26.8 million.
The Company remains optimistic regarding the remainder of the year based upon its performance thus far. Integration of Star Buds is proceeding above expectations including the synergies between the operating companies. However, there are a number of challenges from external factors that may have an unknown impact on the overall business, such as Covid-19, government stimulus, and legislation.
The Company will provide an updated 2021 outlook in its upcoming earnings release.
Participation in Virtual Investor Conferences in May
In May the Company will participate in the following virtual investor conferences:
Alliance Global Partners - Spring 2021 Consumer Cannabis Conference – May 4, 2021
Canaccord Genuity - Cannabis Conference – May 11, 2021
Investors are advised to contact their respective salesperson to schedule a meeting with the Company.
About Schwazze
Schwazze (OTCQX: SHWZ) is building the premier vertically integrated cannabis company in Colorado and plans to take its operating system to other States where it can develop a differentiated leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale. The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition. Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company's leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector. Schwazze is passionate about making a difference in our communities, promoting diversity and inclusion, and doing our part to incorporate climate-conscious best practices. Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc.
Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth.
Forward-Looking Statements
This press release contains preliminary financial data for the Company’s fiscal quarter ended March 31, 2021. This preliminary financial data consists of estimates derived from the Company’s internal books and records and has been prepared by, and are the responsibility of, the Company’s management. The preliminary financial data are subject to the completion of financial closing procedures, final adjustments and other developments that may arise between now and the time the financial results for the Company’s fiscal quarter ended March 31, 2021 are finalized. Therefore, actual results may differ materially from these preliminary financial data and all of these preliminary financial data are subject to change.
This press release contains “forward-looking statements.” Such statements may be preceded by the words “may,” “will,” “expects,” “estimates”, “predicts,” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; (v) difficulties in securing regulatory approval to market our products and product candidates; (vi) our ability to successfully execute our growth strategy in Colorado and outside the state, (vii) our ability to identify and consummate future acquisitions that meet our criteria, (viii) our ability to successfully integrate acquired businesses and realize synergies therefrom, (ix) the actual revenues derived from the Company’s Star Buds assets, (x) the Company’s ability to generate positive cash flow for the rest of 2021, (xi) the ongoing COVID-19 pandemic, (xii) the timing and extent of governmental stimulus programs, and (xiii) the uncertainty in the application of federal, state and local laws to our business, and any changes in such laws. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.
https://cts.businesswire.com/ct/CT?id=bwnews&sty=20210429005656r1&sid=acqr8&distro=nx&lang=en
View source version on businesswire.com: https://www.businesswire.com/news/home/20210429005656/en/
Investors
Raphael Gross, ICR
ir@schwazze.com
203-682-8253
Media
Julie Suntrup, Schwazze
Vice President | Marketing & Merchandising
julie.suntrup@schwazze.com
303-371-0387
Source: Schwazze
© Copyright Business Wire 2021
Great, thanks Matteo2017.
Thanks. Do you have a link?
Lol, if you think it does good for the ticker pps to post such info... such as providing quick, enticing and eye-catching info for those who may be prospecting the stock (aka possible buyers), why not make it easy for folks by simply providing source / link info??
I suggest this only because that's exactly what I do for most stocks that I hold long, when I do post info for those stocks. I've been holding this one for a good while now, so maybe I don't really need/want to know these things, but you can bet there are a lot of iHubbers who do.
A good handful are following the board, but many more readers are not following. And many are perched and ready to attack the ask to fuel a run if/when given a reason.
GLTA
Thank you. When was it posted?
Source?
$RXMD Your selected quotation for defining the use and application of a Confidential S-1 is simply "lawyer speak" that inverts the actual/typical use in practice.
So let's be totally transparent about the fact that this is simply the way ONE law group (actually one single person, Brenda Hamilton) chose to "dumb down" an explanation for the use/application of a Confidential S-1, and it is NOT the SEC's definition.
The appropriate way to read this - ESPECIALLY under the circumstances here - is "...until the company is READY TO EXECUTE a public offering."
The company cannot simply flip a switch on something like this, as the SEC requires a back-and-forth with the company until they (the SEC) are satisfied with the entire prospectus and offering plan. HOWEVER, MANY aspects of such plans are "public-sensitive" such that the company cannot make their intentions known months in advance of the execution. In such cases, the company keeps the S-1 confidential until,
a) they have satisfied the SEC and know that they can EFFECT the S-1, and
b) once "a)" is completed, they've queued up all other aspects of the planned corporate actions, M&A agreements, etc.
FULL DISCLOSURE ON YOUR SOURCE OF INFORMATION
The root source of your quote is:
https://www.securitieslawyer101.com/2019/draft-form-s-1-registration-statements/
There are other sources of that quote, but the ones that properly provide THEIR source link back to the above-noted root source.
So what is Securities Lawyer 101?
It is an informational site published by Hamilton & Associates Law Group, P.A., out of Boca Raton, Florida, founded by Brenda Hamilton in 1999.
https://www.linkedin.com/company/hamilton-&-associates-law-group-p-a-/
And here's ANOTHER Brenda Hamilton site, bh.org, with another reference to that same page on the Securities Lawyer 101 site:
https://www.hg.org/legal-articles/confidential-submission-of-draft-sec-registration-statements-30645
Your exact quotation, as follows, can be seen on the above linked pages of this individual lawyer:
$OWPC That's awesome news today! One World Pharma is warming up this news cycle, only a matter of time til folks begin flocking to OWPC!
$OWPC Great news! Nice to see the advisory board further strengthened as One World Pharma is teeing up for major milestones throughout the coming weeks and months.
$RXMD One thing for sure - no one including CFGN and Joe Retailer was anxious to sell any cheap shares today. I picked up 130k more at over .11 and then sat on the bid all day and didn't get one more share filled. But that's okay, I got my weekly fix from .10s to .12s, and I just wonder what price I'll be paying for my dose next week. Expecting to pay more, of course, but I don't mind a bit.
So... do "we" need to have an update or is your worry unnecessary? I am confused. May I suggest working on your due diligence efforts, read the PRs and filings? Here are the links:
https://www.otcmarkets.com/stock/RXMD/news
https://www.otcmarkets.com/stock/RXMD/disclosure
As far as I know, "we" are pretty confident with our investments in Progressive Care, Inc. (RXMD) and aren't overly anxious if management doesn't repeat weekly or monthly that the plan hasn't changed, still moving forward. Management has kept moving forward and showing an awesome record of continuous growth and achievement of milestones and goals Q to Q, Y over Y for years now. Slow your roll and just be chill, maybe?
$RXMD Nice work, Archer. Thanks for posting!
$RXMD Great post! Readers-be sure to scroll down and read the second half of this post!!
$RXMD I don't worry about the day to day, here. At all. And as far as movement goes... don't worry, in addition to certain accredited/sophisticated investors wanting a substantial piece of RXMD on uplist, there are a boatload of deep-pocket traders (currently 746 total are following) that load only a piece of their target position "at the bottom," and will slap crazy when the price begins/confirms the next move.
Patiently waiting... and habitually loading on dips due to lack of self-control. My name is MFN, and I...
$OWPC Yup! And another $250K installment from the CEO today! I just keep on loading, lol.
$ALPP Yeah, they were really working on it pre-market. Nice dip for loading, but I don't think it will last. Get 'em while you can.
$JUSHF I always like "gain" and "rapid," but I'm a lot like our CEO - the longer it takes, the better. Because Jushi is run by an awesome management team, the longer it takes to legalize, the better for revenue/profit and market share posturing. I KNOW they're setting up for a buyout in a year or two by BIG boys, and I'm thinking $50-$100 per share 1 to 2-1/2 years from now.
That being said, I've been able to load so much more on this pullback than I dreamed I'd be able to accumulate... love the dips, but won't complain when we touch the sky! I just know it's going to happen, and I don't worry too much about how long it takes - it's actually been happening (price appreciation) VERY rapidly - without the worrying, lol.
$OWPC Looking forward to the report. Should provide a nice snapshot of the CEO's capital infusion to-date so all can see. $3M total investment and, if I remember correctly, the entire $3M payment for stock will be completed by June/July.
Oh, is that insider buying? Of course it is. It's not on the open market, it's at the price of $0.15 per share. That's lower than the market price, right? Yeah, that's right. But since no one knows about the company/stock, and there's no real volume yet... for $3M I think the CEO should get a DAMN good price.
If this is insider buying, wouldn't that create a lot of interest?!? Oh yes, it would. If investors actually knew about it. Our day will come.
This business is not being funded by convertible debt, and not by ongoing/daily dilution via Reg A stock sales.
CEO Isiah Thomas (former NBA player, coach, and business executive and currently an NBA analyst for TNT) has invested $3M in the business.
Just FYI, Isiah Thomas (our CEO), a point guard and 12-time NBA All-Star, was named one of the 50 Greatest Players in NBA History and inducted into the Naismith Memorial Basketball Hall of Fame. He played his entire professional career for the Detroit Pistons of the National Basketball Association (NBA).
Much more can be said about Thomas' basketball career, but he's also a businessman. Just to highlight an interesting part of his business career, note that in April 1999 Thomas became the first African American elected to the Board of Governors of the Chicago Stock Exchange. He served until 2002.
https://en.wikipedia.org/wiki/Isiah_Thomas
Amazing that more have not wised up to the opportunity here yet, but I've been enjoying the opportunity to buy cheap capitulation shares, and I know I'm not alone.
Anyone having doubts about this company or the stock price trajectory? Have a look at the Jushi board when I started it back in 2019, and see where it's gone since then. This is a real deal, and it's going to surprise some folks that have sold. Just saying... I'm happy picking up a lot more than I thought I'd be able to, but... THINK, people! I did the same thing with Jushi - I'll keep buying as low as folks are willing to sell, because I believe this is going UP, UP, UP. And soon.
$RXMD That's great info there in the links, INSTA, a good summary of the situation. Thanks for posting!
$RXMD Thanks for posting these video links about PBM and DIR fees, RIO. Very informative. For those interested to know more about how these fees and trends affect RXMD / Progressive Care, I suggest watching these two 5-minute videos and then downloading the audited Dec 31, 2020 annual report that was just filed.
Once downloaded, do an Advanced Search using Acrobat, and search for PBM. Step through the search results locations in the report and you will find, first, definitions for the terms - which pair well with the info from the videos - and second, informative details about how these fees have been impacting Progressive Care, Inc.
From the above exercise, you will understand just how well Progressive Care / PharmcoRX have been doing with navigating through all of this regulatory, administrative crap in our health care system - to grow the way the company has been growing, and to be right at the cusp of profitability as well.
I think the increase in attention to the impact PBMs are having on service providers and consumers is going to build a head of steam and, at some point soon, will yield a windfall of sorts for "small" pharmacy entities like Progressive Care / PharmcoRX (RXMD). Such a windfall would likely result in a very dramatic increase in operational net profits almost immediately.
Annual Report - Consolidated Financial Statements for the Year Ended December, 31 2020
https://backend.otcmarkets.com/otcapi/company/financial-report/276521/content